P. Ferrera

发表

Aberrant opioid use behaviour in advanced cancer

S. Mercadante, Claudio Adile, W. Tirelli, 2020, BMJ Supportive & Palliative Care.

High-dose furosemide and small-volume hypertonic saline solution infusion for the treatment of leg edema in advanced cancer patients.

S. Mercadante, P. Ferrera, P. Villari, 2009, Journal of pain and symptom management.

Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients.

S. Mercadante, L. Verna, G. Porzio, 2009, The journal of pain : official journal of the American Pain Society.

Low doses of transdermal buprenorphine in opioid-naive patients with cancer pain: a 4-week, nonrandomized, open-label, uncontrolled observational study.

S. Mercadante, L. Verna, W. Tirelli, 2009, Clinical therapeutics.

Low morphine doses in opioid-naive cancer patients with pain.

C. Ficorella, F. Fulfaro, S. Mercadante, 2006, Journal of pain and symptom management.

Sustained‐release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management

C. Ficorella, F. Fulfaro, S. Mercadante, 2008, European journal of pain.

Controlled sedation for refractory symptoms in dying patients.

S. Mercadante, P. Ferrera, A. Casuccio, 2009, Journal of pain and symptom management.

Effects of red blood cell transfusion on anemia-related symptoms in patients with cancer.

S. Mercadante, Antonello Giarratano, P. Ferrera, 2009, Journal of palliative medicine.

Patients' and relatives' perceptions about intravenous and subcutaneous hydration.

S. Mercadante, P. Ferrera, A. Casuccio, 2005, Journal of pain and symptom management.

Optimization of opioid therapy for preventing incident pain associated with bone metastases.

S. Mercadante, P. Ferrera, A. Casuccio, 2004, Journal of pain and symptom management.

Efficacy of Haloperidol in the Treatment of Nausea and Vomiting in the Palliative Patient: A Systematic Review

P. Ferrera, 2001 .

Pamidronate in incident pain due to bone metastases.

S. Mercadante, P. Ferrera, P. Villari, 2001, Journal of pain and symptom management.

Local anesthetic switching for intrathecal tachyphylaxis in cancer patients with pain.

S. Mercadante, P. Ferrera, P. Villari, 2003, Anesthesia and analgesia.

Itraconazole-fentanyl interaction in a cancer patient.

S. Mercadante, P. Ferrera, P. Villari, 2002, Journal of pain and symptom management.

Sleep Disturbances in Patients With Advanced Cancer in Different Palliative Care Settings.

M. Valenti, F. Masedu, C. Ficorella, 2015, Journal of pain and symptom management.

The Palliative-Supportive Care Unit in a Comprehensive Cancer Center as Crossroad for Patients’ Oncological Pathway

P. Marchetti, S. Mercadante, Claudio Adile, 2016, PloS one.

Addition of a second opioid may improve opioid response in cancer pain: preliminary data

S. Mercadante, P. Ferrera, A. Casuccio, 2004, Supportive Care in Cancer.

Factors Influencing Clinical and Setting Pathways After Discharge From an Acute Palliative/Supportive Care Unit

S. Mercadante, Claudio Adile, P. Ferrera, 2019, American journal of clinical oncology.

Characteristics and care pathways of advanced cancer patients in a palliative-supportive care unit and an oncological ward

P. Marchetti, S. Mercadante, Claudio Adile, 2018, Supportive Care in Cancer.

Characteristics of patients with an unplanned admission to an acute palliative care unit

S. Mercadante, Claudio Adile, P. Ferrera, 2017, Internal and Emergency Medicine.

Comparison between standard and ultrasound-integrated approach for risk stratification of syncope in the emergency department

E. Pivetta, P. Ferrera, F. Dipaola, 2022, Internal and Emergency Medicine.

Hyperalgesia: an emerging iatrogenic syndrome.

S. Mercadante, P. Ferrera, P. Villari, 2003, Journal of pain and symptom management.

Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.

S. Mercadante, S. Mangione, P. Ferrera, 2009, Journal of pain and symptom management.

Delirium assessed by Memorial Delirium Assessment Scale in advanced cancer patients admitted to an acute palliative/supportive care unit

S. Mercadante, Claudio Adile, A. Cortegiani, 2017, Current medical research and opinion.

Characteristics of advanced cancer patients who were readmitted to an acute palliative/supportive care unit

S. Mercadante, Claudio Adile, P. Ferrera, 2017, Supportive Care in Cancer.

A model of acute symptom control unit: Pain Relief and Palliative Care Unit of La Maddalena Cancer Center

S. Mercadante, P. Ferrera, P. Villari, 2003, Supportive Care in Cancer.

Personalized goal for insomnia and clinical response in advanced cancer patients

M. Maltoni, S. Santis, M. Rosati, 2020, Supportive Care in Cancer.

Personalized Goal for Dyspnea and Clinical Response in Advanced Cancer Patients.

M. Maltoni, M. Rosati, S. Mercadante, 2019, Journal of pain and symptom management.

The effects of alcoholism and smoking on advanced cancer patients admitted to an acute supportive/palliative care unit

S. Mercadante, Claudio Adile, P. Ferrera, 2017, Supportive Care in Cancer.

Tapentadol in cancer pain management: a prospective open-label study

C. Ficorella, S. Mercadante, Claudio Adile, 2012, Current medical research and opinion.

Intrathecal Treatment in Cancer Patients Unresponsive to Multiple Trials of Systemic Opioids

S. Mercadante, S. Mangione, P. Ferrera, 2007, The Clinical journal of pain.

Aggressive pharmacological treatment for reversing malignant bowel obstruction.

S. Mercadante, P. Ferrera, P. Villari, 2004, Journal of pain and symptom management.

Prevalence of Opioid-Related Dysuria in Patients With Advanced Cancer Having Pain

S. Mercadante, P. Ferrera, A. Casuccio, 2011, The American journal of hospice & palliative care.

Symptom Expression in Patients with Advanced Cancer Admitted to an Acute Supportive/Palliative Care Unit With and Without Delirium.

S. Mercadante, Claudio Adile, A. Cortegiani, 2018, The oncologist.

Barriers and Adherence to Pain Management in Advanced Cancer Patients

S. Mercadante, Claudio Adile, W. Tirelli, 2020, Pain practice : the official journal of World Institute of Pain.

Burst ketamine to reverse opioid tolerance in cancer pain.

S. Mercadante, P. Ferrera, P. Villari, 2003, Journal of pain and symptom management.

High doses of oxycodone–naloxone combination may provide poor analgesia

S. Mercadante, P. Ferrera, C. Adile, 2011, Supportive Care in Cancer.

Naloxone in treating central adverse effects during opioid titration for cancer pain.

S. Mercadante, P. Ferrera, P. Villari, 2003, Journal of pain and symptom management.

Poor Social Conditions, Criminality and Urban Violence: Unmentioned Barriers for Effective Cancer Pain Control at the End of Life

S. Mercadante, P. Ferrera, P. Villari, 2003 .

Association between alcoholism and symptom expression, patient symptom goals, and clinical response in advanced cancer patients

S. Mercadante, P. Ferrera, A. Casuccio, 2019, Supportive Care in Cancer.

Dialogues on complex analgesic strategies for difficult pain syndromes

S. Mercadante, P. Ferrera, P. Villari, 2004, Supportive Care in Cancer.

Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain.

S. Mercadante, S. Mangione, P. Ferrera, 2005, Journal of pain and symptom management.

Outcome of opioid switching 4 weeks after discharge from a palliative care unit

S. Mercadante, P. Ferrera, A. Casuccio, 2011, Current medical research and opinion.

The Use of Opioids in the Last Week of Life in an Acute Palliative Care Unit

S. Mercadante, P. Ferrera, A. Casuccio, 2010, The American journal of hospice & palliative care.

Clinical and financial analysis of an acute palliative care unit in an oncological department

S. Mercadante, S. Mangione, P. Ferrera, 2008, Palliative medicine.

Rapid switching between transdermal fentanyl and methadone in cancer patients.

S. Mercadante, P. Ferrera, A. Casuccio, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Palliative Care in the Time of COVID-19

S. Mercadante, P. Ferrera, C. Adile, 2020, Journal of Pain and Symptom Management.

The Effects of Low Doses of Pregabalin on Morphine Analgesia in Advanced Cancer Patients

S. Mercadante, G. Porzio, C. Lo Presti, 2013, The Clinical journal of pain.

Does pain intensity predict a poor opioid response in cancer patients?

C. Ficorella, S. Mercadante, L. Verna, 2011, European journal of cancer.

Conversion ratios for opioid switching: a pragmatic study

S. Mercadante, P. Ferrera, A. Casuccio, 2022, Supportive Care in Cancer.

Opioid-induced hyperalgesia after rapid titration with intravenous morphine: Switching and re-titration to intravenous methadone.

S. Mercadante, P. Ferrera, A. Casuccio, 2012, Annals of palliative medicine.

The Use of High Doses of Oxycodone in an Acute Palliative Care Unit

S. Mercadante, P. Ferrera, A. Casuccio, 2011, The American journal of hospice & palliative care.

Intravenous morphine for breakthrough (episodic-) pain in an acute palliative care unit: a confirmatory study.

S. Mercadante, S. Mangione, P. Ferrera, 2008, Journal of pain and symptom management.

Opioid plasma concentrations during a switch from transdermal fentanyl to methadone.

S. Mercadante, P. Ferrera, A. Casuccio, 2007, Journal of palliative medicine.

Opioid escalation in patients with cancer pain: the effect of age.

S. Mercadante, P. Ferrera, A. Casuccio, 2006, Journal of pain and symptom management.

Unexpected Death on an Acute Palliative Care Unit.

S. Mercadante, P. Ferrera, A. Casuccio, 2016, Journal of pain and symptom management.

Refractory death rattle: deep aspiration facilitates the effects of antisecretory agents.

S. Mercadante, P. Ferrera, P. Villari, 2011, Journal of pain and symptom management.

Clinical Problems with Transdermal Fentanyl Titration from 25 to 50 μg/hr

S. Mercadante, P. Ferrera, P. Villari, 2001 .

Clinical problems with transdermal fentanyl titration from 25 to 50 microg/hr.

S. Mercadante, P. Ferrera, P. Villari, 2001, Journal of pain and symptom management.

Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion

F. Fulfaro, S. Mercadante, P. Ferrera, 2002, Cancer.

Is there a ceiling effect of transdermal buprenorphine? Preliminary data in cancer patients

S. Mercadante, P. Ferrera, P. Villari, 2007, Supportive Care in Cancer.

Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine.

S. Mercadante, L. Verna, G. Porzio, 2006, Journal of pain and symptom management.

Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients

M. Valenti, F. Masedu, S. Mercadante, 2015, Supportive Care in Cancer.

Opioid Switching and Burst Ketamine to Improve the Opioid Response in Patients With Movement-related Pain Due to Bone Metastases

S. Mercadante, P. Ferrera, P. Villari, 2009, The Clinical journal of pain.

Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain

S. Mercadante, S. Mangione, P. Ferrera, 2007, British Journal of Cancer.

When the game is hard, more complex weapons are needed

S. Mercadante, P. Ferrera, C. Adile, 2022, BMJ supportive & palliative care.

Cystic masses in the floor of the mouth: value of MR imaging in planning surgery.

T. Vogl, G. Grevers, P. Ferrera, 1993, AJR. American journal of roentgenology.

Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain dose and background dose.

S. Mercadante, P. Ferrera, A. Casuccio, 2011, Journal of pain and symptom management.

Epidemiology and Characteristics of Episodic Breathlessness in Advanced Cancer Patients: An Observational Study.

M. Valenti, F. Masedu, P. Marchetti, 2016, Journal of pain and symptom management.

Episodic Breathlessness with and without Background Dyspnea in Advanced Cancer Patients Admitted to an Acute Supportive Care Unit

S. Mercadante, G. Bonanno, P. Ferrera, 2020, Cancers.

The Prevalence and Characteristics of Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain

M. Maltoni, M. Rosati, S. Mercadante, 2021, Cancers.

Personalized Pain Goals and Responses in Advanced Cancer Patients.

M. Maltoni, M. Rosati, S. Mercadante, 2019, Pain medicine.

Personalized Symptom Goals and Patient Global Impression on Clinical Changes in Advanced Cancer Patients.

M. Maltoni, M. Valenti, F. Masedu, 2019, The oncologist.

Methadone as First-line Opioid for the Management of Cancer Pain

S. Mercadante, M. Ricci, G. Bonanno, 2022, The oncologist.

Opioid plasma concentration during switching from morphine to methadone: preliminary data

F. Fulfaro, S. Mercadante, V. Gebbia, 2003, Supportive Care in Cancer.

Low doses of transdermal fentanyl in opioid-naive patients with cancer pain

C. Ficorella, S. Mercadante, P. Ferrera, 2010, Current medical research and opinion.

Rapid titration with intravenous oxycodone for severe cancer pain and oral conversion ratio.

S. Mercadante, P. Ferrera, A. Casuccio, 2022, Journal of pain and symptom management.

Lung Ultrasound ‐ Implemented Diagnosis of Acute Decompensated Heart Failure in the

M. Maule, P. Tizzani, G. Volpicelli, 2022 .

Lung Ultrasonography for the Diagnosis of SARS-CoV-2 Pneumonia in the Emergency Department

M. Avolio, M. Maule, L. Richiardi, 2020, Annals of Emergency Medicine.

Cisplatin and vinorelbine in advanced and/or metastatic adenocarcinoma of the endometrium: a new highly active chemotherapeutic regimen.

V. Gebbia, P. Ferrera, V. Gebbia, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

The Use of Opioids for Breakthrough Pain in Acute Palliative Care Unit by Using Doses Proportional to Opioid Basal Regimen

S. Mercadante, S. Mangione, P. Ferrera, 2010, The Clinical journal of pain.

Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose.

S. Mercadante, P. Ferrera, A. Casuccio, 2004, Journal of pain and symptom management.

The use of fentanyl buccal tablets as breakthrough medication in patients receiving chronic methadone therapy: an open label preliminary study

S. Mercadante, P. Ferrera, E. Arcuri, 2011, Supportive Care in Cancer.

Original article Tapentadol in cancer pain management: a prospective open-label study

S. Mercadante, G. Porzio, P. Ferrera, 2012 .

Phase I–II Parallel Study of Docetaxel on a Bimonthly Schedule in Refractory Metastatic Breast Carcinoma

V. Gebbia, P. Ferrera, N. Borsellino, 2004, Breast Cancer Research and Treatment.

Pegylated Liposomal Doxorubicin with Vinorelbine in Metastatic Breast Carcinoma

V. Gebbia, P. Ferrera, N. Borsellino, 2002, Oncology.

Dual opioid therapy in a cancer patient with myasthenia gravis who developed respiratory depression from codeine

S. Mercadante, P. Ferrera, C. Adile, 2021, BMJ Supportive & Palliative Care.

Peritoneal catheter for continuous drainage of ascites in advanced cancer patients

S. Mercadante, P. Ferrera, P. Villari, 2008, Supportive Care in Cancer.

Opioid‐induced or pain relief‐reduced symptoms in advanced cancer patients?

S. Mercadante, P. Ferrera, A. Casuccio, 2006 .

Sleep disturbances in advanced cancer patients admitted to a supportive/palliative care unit

M. Valenti, F. Masedu, S. Mercadante, 2017, Supportive Care in Cancer.

Maddalena Opioid Switching Score (MOSS) in patients with cancer pain.

S. Mercadante, P. Ferrera, A. Casuccio, 2022, Pain.

Switching from oxycodone to methadone in advanced cancer patients

S. Mercadante, P. Ferrera, A. Casuccio, 2011, Supportive Care in Cancer.

Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine.

S. Mercadante, L. Verna, G. Porzio, 2006, Journal of pain and symptom management.

Symptom hyper-expression in advanced cancer patients with anxiety and depression admitted to an acute supportive/palliative care unit

S. Mercadante, A. Cortegiani, P. Ferrera, 2019, Supportive Care in Cancer.

When the Progression of Disease Lowers Opioid Requirement in Cancer Patients

S. Mercadante, W. Tirelli, P. Ferrera, 2010, The Clinical journal of pain.

Opioid-induced or pain relief-reduced symptoms in advanced cancer patients?

S. Mercadante, P. Ferrera, A. Casuccio, 2006, European journal of pain.

Local anesthetics for breakthrough pain in patients receiving intrathecal treatment for cancer pain management.

S. Mercadante, P. Ferrera, P. Villari, 2005, Anesthesia and analgesia.

When the Progression of Disease Lowers Opioid Requirement in Cancer Patients

S. Mercadante, W. Tirelli, P. Ferrera, 2010, The Clinical journal of pain.

Characteristics and care pathways of advanced cancer patients in a palliative-supportive care unit and an oncological ward

P. Marchetti, S. Mercadante, P. Ferrera, 2018, Supportive Care in Cancer.

Lung Ultrasound-Implemented Diagnosis of Acute Decompensated Heart Failure in the ED: A SIMEU Multicenter Study.

M. Maule, P. Tizzani, G. Volpicelli, 2015, Chest.

Opioid-induced hyperalgesia after rapid titration with intravenous morphine: Switching and re-titration to intravenous methadone.

S. Mercadante, P. Ferrera, A. Casuccio, 2012, Annals of palliative medicine.

Pain Catastrophizing in Cancer Patients

S. Mercadante, P. Ferrera, Alessio Lo Cascio, 2024, Cancers.